IL281845B2
Combination therapy comprising 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and daratumumab for the treatment multiple myeloma
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US2014045843A1 | Cites | United States of America | Search report |
| US2016051530A1 | Cites | United States of America | Search report |
| DIMOPOULOS MA ET AL., DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE FOR MULTIPLE MYELOMA, 6 October 2016 (2016-10-06) | Non-patent | – | Search report |
22 members in 13 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 62739809 | United States of America | – | |
| 201862739809 | United States of America | P | |
| 62773980 | United States of America | – | |
| 201862773980 | United States of America | P | |
| 2019053721 | United States of America | W |
Members22
| Document | Office | Kind | |
|---|---|---|---|
| US2020101058A1 | United States of America | A1 | |
| CA3114401A1 | Canada | A1 | |
| WO2020072334A1 | World Intellectual Property Organization (WIPO) | A1 | |
| SG11202103141YA | Singapore | A | |
| AU2019351811A1 | Australia | A1 | |
| CN112839658A | China | A | |
| MX2021003842A | Mexico | A | |
| IL281845A | Israel | A | |
| IL281845D0 | Israel | D0 | |
| KR20210069642A | Republic of Korea | A | |
| EA202190865A1 | Eurasian Patent Organization (EAPO) | A1 | |
| BR112021006318A2 | Brazil | A2 | |
| EP3860610A1 | European Patent Office (EPO) | A1 | |
| JP2022508513A | Japan | A | |
| EP3860610A4 | European Patent Office (EPO) | A4 | |
| US11529339B2 | United States of America | B2 | |
| US2023277517A1 | United States of America | A1 | |
| JP7466549B2 | Japan | B2 | |
| CN112839658B | China | B | |
| AU2019351811B2 | Australia | B2 | |
| IL281845B1 | Israel | B1 | |
| IL281845B2This record | Israel | B2 |
Numbers
- Publication
- 281845
- Application
- 281845
Titles2
- English
- COMBINATION THERAPY COMPRISING 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND DARATUMUMAB FOR THE TREATMENT MULTIPLE MYELOMA
- Hebrew
- טיפול משולב הכולל 3-(4-((4-(מורפולינומתיל)בנזיל)אוקסי)-1-אוקסואיזואנדולין-2-איל)פיפרידין-2,6-דיון ודראטומומב לטיפול במיאלומה נפוצה
Classification
- CPC, 11
- A61K31/5377
- A61K31/45
- A61P35/00
- A61K31/573
- A61K2300/00
- A61K39/39558
- C07K16/2896
- A61K9/0019
- A61P31/00
- A61K47/6849
- A61K39/3955
- IPC, 8
- A61K31 5377
- A61P35 00
- A61P31 00
- A61K9 00
- A61K47 68
- A61K39 395
- A61K31 45
- A61K31 573